|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents: | ||||||||||||||||||||
| Cash and balances due from banks | ||||||||||||||||||||
| Interest-bearing deposits in other banks | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Available-for-sale investment securities, at fair value (amortized cost of $966,592 at June 30, 2026 and $1,076,980 at December 31, 2025) | ||||||||||||||||||||
| Held-to-maturity investment securities, at amortized cost (fair value of $802,716 at June 30, 2026 and $867,714 at December 31, 2025) | ||||||||||||||||||||
| Other investments | ||||||||||||||||||||
| Total investment securities | ||||||||||||||||||||
| Loans and leases, net of deferred fees and costs | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| Net loans and leases | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Bank premises and equipment, net of accumulated depreciation | ||||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Non-interest-bearing | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Long-term borrowings | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity | ||||||||||||||||||||
| Preferred shares, no par value, $50,000 shares authorized, no shares issued at June 30, 2026 or at December 31, 2025 | ||||||||||||||||||||
| Common shares, no par value, $50,000,000 shares authorized, $36,860,845 shares issued at June 30, 2026 and $36,836,943 shares issued at December 31, 2025, including at each date shares held in treasury | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss, net of deferred income taxes | ||||||||||||||||||||
| Treasury stock, at cost, $1,008,699 shares at June 30, 2026 and $1,215,120 shares at December 31, 2025 | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
